Skip to main content
Clinical Trials/NCT05099679
NCT05099679
Completed
Not Applicable

A Pilot Study for Optimizing Mental Wellbeing and Heart Health for Black Patients With Prostate Cancer

Stanford University1 site in 1 country14 target enrollmentNovember 18, 2021
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Stanford University
Enrollment
14
Locations
1
Primary Endpoint
Proportion of Completers
Status
Completed
Last Updated
last year

Overview

Brief Summary

Pilot study to determine the feasibility of providing psychosocial and cardiac rehabilitation services to address socioeconomic health disparities and improve wellbeing for black men with prostate cancer.

Detailed Description

Subjects will see an oncology Associate Clinical Social Worker at Stanford's Cancer Center for a two hour psychosocial assessment. Subsequently participants will complete the psychosocial intake support session and elective additional counseling sessions (Part A) at the end of up to 8 counseling sessions (maximum sessions possible) or 20 weeks (+/- 4 weeks), whichever comes first. For participants who continue onto cardiac services (Part B), the participant will complete the cardiac rehabilitation exercise program within 12 weeks (+/- 2 weeks) of the first day of exercise start. The end of study will occur after the last cardiac rehabilitation exercise session (+ 2 weeks).

Registry
clinicaltrials.gov
Start Date
November 18, 2021
End Date
December 20, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alice Fan

Associate Professor of Medicine (Oncology) and, by courtesy, of Urology

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Proportion of Completers

Time Frame: 12 weeks

Proportion of screened eligible participants who complete the initial 2-hour psychosocial support session intake. The pilot study is considered feasible if the primary endpoint is met in at least 50% of patients. We will evaluate the 95% CI of the feasibility rate.

Secondary Outcomes

  • Difference of General Anxiety Disorder-7 (GAD-7) score(12 weeks)
  • Difference of Functional Assessment of Cancer Therapy-Prostate (FACT-P) score(12 weeks)
  • Difference in Patient Health Questionnaire-9 (PHQ-9)(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials